Mohammad A Sayem

SRSF2 mutation reduces polycythemia and impairs hematopoietic progenitor functions in JAK2V617F-driven myeloproliferative neoplasm

G. Mohi, Avik Dutta, Yue Yang, 2023, Blood cancer journal.

Immune-resistant mechanisms in cancer immunotherapy

S. Ohta, Y. Kawakami, T. Yaguchi, 2020, International Journal of Clinical Oncology.

Inhibition of vascular adhesion protein‐1 enhances the anti‐tumor effects of immune checkpoint inhibitors

H. Asamura, S. Ohta, Y. Kawakami, 2021, Cancer science.